Variant Bio has entered a multi-year research partnership with Novo Nordisk, focusing on the identification of new targets to treat metabolic conditions. Leveraging Variant’s ‘VB-Inference analysis’ ...
A new study has identified a group of neurons that, when activated, can induce a hypometabolic state, akin to hibernation. The discovery could have far-reaching implications for conditions like ...
Brain is by far the most complex organ in the body. It is involved in the regulation of cognitive, behavioral, and emotional activities. The organ is also a target for many diseases and disorders ...
Tenvie Therapeutics has launched with $200 million and a clutch of assets from Denali Therapeutics to go after neurological diseases with small molecules. Backed by ARCH Venture Partners, F-Prime ...
Patients with celiac disease who had concurrent autoimmune or metabolic-related diseases had further heightened risks. "The absolute risk difference for any chronic liver disease between patients ...
offering a new way to help the treatment of inflammatory diseases. It can predict metabolic reactions within the bacterial strains in the gut that may be targeted to correct the dysbiosis ...